Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK (BMJ Open, 2024)

(untitled) - Blackstone, J; Williams, T; Nicholas, JM; Bordea, E; De Angelis, F; Bianchi, A; Calvi, A; Doshi, A; John, N; Apap Mangion, S; Wade, C; Merry, R; et al.